palbociclib with adjuvant endocrine therapy in early breast cancer - pallas study
Published 3 years ago • 86 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
2:43
adjuvant palbociclib strikes out in pallas trial | erica mayer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
6:36
adjuvant cdk4/6 inhibition in early-stage hr-positive breast cancer | ruth o'regan
-
4:19
asco 2024 palbociclib, pembrolizumab & endocrine therapy: outcomes & gut microbiome in hr /her2- mbc
-
0:44
patricia: phase ii study of palbociclib, trastuzumab, and endocrine therapy in her2 advanced bc
-
5:47
monarche and pallas: a tale of two cdk4/6 inhibitors | george sledge jr
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
1:12
dr. joseph sparano on the role of endocrine therapy in breast cancer
-
2:33
challenges with neoadjuvant endocrine therapy in breast cancer
-
13:22
palbociclib and breast cancer
-
1:19:26
adjuvant endocrine therapy in hormone receptor-positive breast cancer sandy ruiz-cruz, md
-
2:47
adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from soft
-
1:31
pallas clinical trial for breast cancer patients